Repatha prefilled syringes and SureClick autoinjectors come in one strength: 140 milligrams per milliliter (mg/mL). For more details about these methods for Repatha injections, check out this ...

Patients continuing with Repatha treatment should be transitioned to either the single-dose prefilled syringe (140mg/mL) or the single-dose prefilled SureClick ® autoinjector (140mg/mL).

Repatha, a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), is available as a single-use 140mg/mL prefilled SureClick autoinjector or prefilled ...

Patients receiving subcutaneous injections of Repatha every 2 weeks plus statin (n = 147) ... Repatha SureClick, delivers a 140 mg/mL dose subcutaneously over 15 seconds.

Most Medicare Part D and Advantage plans cover Repatha injections. Read about the cost of Repatha after paying the deductible, generic alternatives, and more.

Amgen's (AMGN) PCSK9 inhibitor Repatha becomes the first and the only one to gain FDA approval for a monthly single-dose administration.

Leqvio (inclisiran) and Repatha (evelocumab) are prescription injectable medications used to treat high cholesterol. They specifically target low-density lipoprotein cholesterol (LDL-C), or "bad ...

Patients are able to perform moderate physical activities (such as walking, reaching or bending) as the 420 mg of Repatha is delivered subcutaneously. The U.S. Wholesale Acquisition Cost (WAC) price ...

The FDA approved Amgen 's AMGN new cholesterol-lowering medication, Repatha (evolocumab), making it the second PCSK9 inhibitor to gain approval in.

Most Medicare Part D and Advantage plans cover Repatha injections. Read about the cost of Repatha after paying the deductible, generic alternatives, and more.

The FDA approved Amgen’s AMGN new cholesterol-lowering medication, Repatha (evolocumab), making it the second PCSK9 inhibitor to gain approval in the U.S. this year. Repatha’s approval comes a ...